CMI Media Group partnered with a leading pharmaceutical brand to drive awareness and consideration for an innovative type 2 diabetes treatment among high-value healthcare professionals (HCPs) specializing in blood sugar management.
Leveraging PulsePoint’s HCP targeting, CMI Media Group helped the brand deliver precision targeting that broader tools couldn’t achieve. With PulsePoint’s near real-time physician level data (PLD) reporting, CMI Media Group could see its campaign exceed benchmarks across key engagement and conversion metrics.
Building on LinkedIn targeting, CMI Media Group’s campaign used PulsePoint’s Omnichannel Audiences as the foundation for HCP audience activation. This seamless integration marries PulsePoint’s clinical and behavioral precision with LinkedIn’s rich professional data such as job titles, specialties and affiliations so messages don’t just reach HCPs, they reach the right HCPs at exactly the right moment.
decrease in CPM
decrease in CPC
increase in impressions
increase in clicks
Using PulsePoint’s Omnichannel Audiences led to significant improvements in campaign efficiency and reach. CMI Media Group’s campaign saw lower costs across key metrics and a substantial increase in both impressions and clicks. This enabled the brand to engage a larger audience of brand-relevant HCPs more effectively, maximizing the impact of their LinkedIn investment.
PulsePoint offers excellent audience scalability on LinkedIn, driving efficiency in both campaign costs and delivery. Most importantly, PulsePoint ensures we are reaching a highly relevant and engaged HCP audience.
CMI Media Group is excited to partner with PulsePoint on their mission to continually enhance HCP targeting capabilities across the non-endemic social media space.
– Will Royal, CMI Media Group
Follow the PulsePoint LinkedIn to explore more success stories and insights.